Home » Topics » BioWorld

BioWorld
RSS

CORTECH CONVERSION RIGHTS EXPIRE

Feb. 8, 1993

RHODE ISLAND BONDS FOR ALPHA-BETA FACILITY

Feb. 8, 1993

EUROPEAN PATENT DISCLOSURES

Feb. 8, 1993

FDA APPROVES IMMUNOCARD

Feb. 8, 1993

AMGEN LEADS BIOTECH STOCK DROP

Feb. 8, 1993

SOMATIX TO WORK WITH PARKINSON'S FOUNDATION

Feb. 8, 1993

EPA APPROVES BIOINSECTICIDE

Feb. 8, 1993

PROBE ABSOLVES MEDAREX -- AGAIN

Feb. 5, 1993

MICROCARB TEST FOR FOOD POISONING AGENT

Feb. 5, 1993

IDEXX COMPLETES ACQUISITION

Feb. 5, 1993

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...